Lakshmi N Rajdev MD

Oncology•New York, NY

Assistant Professor, Medicine, A Einstein College of Medicine of Yeshiva Univ

Join to View Full Profile

100 East 77th StreetNew York, NY 10075
Phone+1 212-434-2675
Fax+1 718-405-8433

Education & Training

NYU Grossman School of MedicineFellowship, Hematology and Medical Oncology, 1995 - 1997
NYU Grossman School of MedicineFellowship, Hematology and Medical Oncology, 1994 - 1995
Icahn School of Medicine at Mount Sinai/Beth IsraelResidency, Internal Medicine, 1991 - 1994
Grant Medical CollegeClass of 1987

Certifications & Licensure

NY State Medical License 1994 - 2026
American Board of Internal Medicine Medical Oncology

Clinical Trials

Sorafenib, Gemcitabine, and Capecitabine in Treating Patients With Unresectable and/or Metastatic Kidney Cancer Start of enrollment: 2005 Jun 03
Completed
Phase 1, Phase 2
OSI-774 (Erlotinib, Tarceva) in Elderly Patients Start of enrollment: 2003 Jul 02
Completed
Phase 2
Radiation Therapy, Paclitaxel, and Carboplatin With or Without Trastuzumab in Treating Patients With Esophageal Cancer Start of enrollment: 2011 Feb 14
Completed
Phase 3
A Phase II Study Of Imtox-25 In Adults With Refractory/Relapsed Cd25 Positive Adult T Cell Leukemia/Lymphoma Start of enrollment: 2010 Sep 01
Terminated
Phase 2
Adjuvant Aflibercept for Metastatic Colorectal Cancer Start of enrollment: 2012 Dec 01
Terminated
Phase 2
A Dose Finding Study of Eribulin Mesylate and Cetuximab For Patients With Advanced Head and Neck and Colon Cancer Start of enrollment: 2012 May 01
Completed
Phase 1, Phase 2
QUILT-3.010: A Study of Gemcitabine and Nab-paclitaxel With or Without NPC-1C to Treat Patients With Pancreatic Cancer Start of enrollment: 2013 Apr 01
Terminated
Phase 1, Phase 2
Sapanisertib in Treating Patients With Metastatic or Refractory Pancreatic Neuroendocrine Tumor That Cannot Be Removed by Surgery Start of enrollment: 2017 Apr 28
Completed
Phase 2
Join now to see all

Publications & Presentations

PubMed

Incorporating Circulating Tumor DNA Testing Into Clinical Trials: A Position Paper by the National Cancer Institute GI Oncology Circulating Tumor DNA Working Group.
Lakshmi Rajdev, Gentry G King, Christopher H Lieu, Stacey A Cohen, Shubham Pant
JCO Precision Oncology. 2025-03-01
2 citations
Systemic Therapy for Stage I-III Anal Squamous Cell Carcinoma: ASCO Guideline.
Van K Morris, Erin B Kennedy, Manik A Amin, Olivia Aranha, Al B Benson 3rd
Journal of Clinical Oncology. 2025-02-10
1 citations
International consensus to define outcomes for trials of chemoradiotherapy for anal cancer (CORMAC-2): defining the outcomes from the CORMAC core outcome set.
Robert Samuel, Stephen R Knight, Richard Adams, Prajnan Das, Jennifer Dorth
Eclinicalmedicine. 2024-12-01

Lectures

AMC 095 (AIDS Malignancy Consortium): A phase I study of ipilimumab (IPI) and nivolumab (NIVO) in advanced HIV associated solid tumors (ST) with expansion cohorts in H...
2018 ASCO Annual Meeting - Chicago, Illinois - 06/4/2018

Professional Memberships

American Society of Clinical Oncology - ASCO
Member

Other Languages

Hindi